Back

Dopamine neuron dysfunction and loss in the PrknR275W mouse model of Juvenile Parkinsonism

Regoni, M.; Zanetti, L.; Sevegnani, M.; Domenicale, C.; Magnabosco, S.; Patel, J. C.; Fernandes, M. K.; Monzani, E.; Comai, S.; Cherchi, L.; Ciammola, A.; Valtorta, F.; Morari, M.; Piccoli, G.; Rice, M. E.; Sassone, J.

2023-09-27 neuroscience
10.1101/2023.09.26.559326 bioRxiv
Show abstract

Mutations in the PRKN gene encoding the protein PARKIN cause Autosomal Recessive Juvenile Parkinsonism (ARJP). Harnessing this mutation to create an early-onset Parkinsons disease (PD) mouse model would provide a unique opportunity to clarify the mechanisms involved in the neurodegenerative process and lay the groundwork for the development of neuroprotective strategies. We created a knock-in mouse carrying the homozygous PrknR275W mutation, which is the missense mutation with the highest allelic frequency in PRKN patients. In PrknR275W mice, we analysed the anatomical and functional integrity of the nigrostriatal pathway, including striatal DA content and evoked striatal dopamine (DA) release, as well as the motor phenotype. We report here that PrknR275W mice show early DA neuron dysfunction, age-dependent loss of DA neurons in the substantia nigra, decreased DA content and stimulus-evoked DA release in the striatum, and progressive motor impairment. Together, these data show that the PrknR275W mouse recapitulates key features of ARJP. Thus, these studies fill a critical need in the field by introducing a promising new PD model in which to study causative mechanisms of the disease, as well as test therapeutic strategies.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.